Repligen (RGEN) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Repligen · Health Care · ref. ETF XLV · 57 calls · price $182.03
What the company does: Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
📈 Repligen (RGEN) stock price
$182.03+49.0% over range
Aug 28, 25low $102.87 · high $182.03Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
89% recommend buying · 9 analysts
📊 JPI status : Repligen has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 RGEN price target & analyst consensus — price $182
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$208+14.3%
Median target · of 9 targets$160-12.1%
Lowest target · 1 firm of 9$145-20.3%
Current price$182.03
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
333%
$185 ↔ $208
Below
667%
$145 ↔ $175
⏳ Targets haven't kept up with the price. 89% of ratings say “Buy”, yet 6 of 9 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Benchmark — 80% of its targets hit on this sector (10 calls tested). It aims for $185 (+1.6 %), call made on July 8, 2026, maturing on July 8, 2027 (51 d ago).
The 2 reliable analysts
$185+1.6 %
The 7 other firms
$160-12 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $185 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy889%
Hold111%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 RGEN price target all
All 57 calls, one by one, with our verdict on each firm.
→ See all 57 targets, analyst by analyst💡 The best analysts on RGEN most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in RGEN? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Repligen? The JPI assistant answers using our backtest data.
📈 Repligen fundamentals: valuation, margins & growth › open the full page
P/E 252.8Net margin 5.3 %Revenue growth +11.9 %Very expensive vs its growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 23 %
2023
Rev −20%Profit −78%
2024
Rev −1%Profit −161%
2025
Rev +16%
🔎 Detailed analyses
✅ Historical analyst reliability on RGEN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Citigroup ↗ | 100% | +78.0% | 2 |
| Stifel ↗ | 86% | +54.7% | 7 |
| Jefferies ↗ | 80% | +69.3% | 5 |
| HC Wainwright & Co. ↗ | 55% | +25.6% | 11 |
| Keybanc ↗ | 43% | -5.4% | 7 |
| Stephens & Co. ↗ | 40% | +10.5% | 5 |
| Wells Fargo ↗ | 33% | -5.7% | 3 |
| Craig-Hallum ↗ | 33% | -10.3% | 3 |
| SVB Leerink | 29% | -1.2% | 7 |
| JP Morgan ↗ | 25% | +0.4% | 8 |
See the other 2 firms
| UBS ↗ | 0% | -15.4% | 3 |
| RBC Capital ↗ | 20% | -9.8% | 10 |
📊 What $1,000 invested in Repligen would be worth › open the full page
In short — $1,000 invested in Repligen 10 years ago would be worth $4,823 today, i.e. +17%/yr on average. Best year: 2020 (+107%), worst: 2022 (-36%). Price performance, excluding dividends.
If I'd invested $1,000 in Repligen
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $948 | -5% |
| 3 years ago | $806 | -19% |
| 5 years ago | $712 | -29% |
Return by year (Repligen)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -17% | $833 (-17%) |
| 2025 | +14% | $948 (-5%) |
| 2024 | -20% | $759 (-24%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Repligen
Loading news…
📋 All analyst calls on RGEN
Filtered on — · ✕ show all
Wells Fargo ↗
Jul 30, 26
▲ Overweight · 🎯$185
Price at call : $141.01 — upside +31%
Today : $182.03 — upside +2%
🎯 on RGEN : 50% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Overweight · 🎯$175
Price at call : $143.6 — upside +22%
Today : $182.03 — upside -4%
🎯 on RGEN : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Buy · 🎯$185
Price at call : $139.83 — upside +32%
Today : $182.03 — upside +2%
🎯 on RGEN : no call matured yet · 📊 on Health : 70% · +18.4% (10 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$160
Price at call : $139.83 — upside +14%
Today : $182.03 — upside -12%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$150
Price at call : $126.55 — upside +19%
Today : $182.03 — upside -18%
🎯 on RGEN : no call matured yet · 📊 on Health : 33.3% · +6.3% (3 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
▲ Overweight · 🎯$165
Price at call : $126.43 — upside +31%
Today : $182.03 — upside -9%
🎯 on RGEN : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Overweight · 🎯$160
Price at call : $126.43 — upside +27%
Today : $182.03 — upside -12%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Canaccord Genuity ↗
Apr 20, 26
■ Hold neutral · not a buy · 🎯$145
Price at call : $132.7 — gap to target +9%
Today : $182.03 — gap to target -20%
🎯 on RGEN : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
See the other 49 calls, newest to oldest
Roth Capital
Apr 17, 26
▲ Buy · 🎯$160
Price at call : $131.99 — upside +21%
Today : $182.03 — upside -12%
🎯 on RGEN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
▲ Overweight · 🎯$145
Price at call : $131.93 — upside +10%
Today : $182.03 — upside -20%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$140
Price at call : $115.29 — upside +21%
Today : $182.03 — upside -23%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
HC Wainwright & Co. ↗
Mar 23, 26
▲ Buy · 🎯$208
Price at call : $116.35 — upside +79%
Today : $182.03 — upside +14%
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Mar 23, 27
matures : Mar 23, 27
▲ Buy · 🎯$195
Price at call : $133.65 — upside +46%
Today : $182.03 — upside +7%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Overweight · 🎯$175
Price at call : $133.65 — upside +31%
Today : $182.03 — upside -4%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Wells Fargo ↗
Feb 25, 26
▲ Overweight · 🎯$180
Price at call : $133.65 — upside +35%
Today : $182.03 — upside -1%
🎯 on RGEN : 50% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Evercore ISI Group ↗
Feb 25, 26
▲ Outperform · 🎯$170
Price at call : $132.14 — upside +29%
Today : $182.03 — upside -7%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$200
Price at call : $163.33 — upside +22%
Today : $182.03 — upside +10%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
▲ Overweight · 🎯$200
Price at call : $158.09 — upside +27%
Today : $182.03 — upside +10%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wells Fargo ↗
Dec 15, 25
▲ Overweight · 🎯$190
Price at call : $158.09 — upside +20%
Today : $182.03 — upside +4%
🎯 on RGEN : 50% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Canaccord Genuity ↗
Oct 29, 25
■ Hold neutral · not a buy · 🎯$165
Price at call : $144.57 — gap to target +14%
Today : $182.03 — gap to target -9%
🎯 on RGEN : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Overweight · 🎯$175
Price at call : $144.57 — upside +21%
Today : $182.03 — upside -4%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$175
Price at call : $150.81 — upside +16%
Today : $182.03 — upside -4%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
▲ Overweight · 🎯$160
Price at call : $145.23 — upside +10%
Today : $182.03 — upside -12%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
▲ Buy · 🎯$150
Price at call : $145.23 — upside +3%
Today : $182.03 — upside -18%
🎯 on RGEN : no call matured yet · 📊 on Health : 33.3% · +6.3% (3 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
Evercore ISI Group ↗
Sep 22, 25
▲ Outperform · 🎯$155
Price at call : $125.94 — upside +23%
Today : $182.03 — upside -15%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Sep 22, 26
matures : Sep 22, 26
■ Hold neutral · not a buy · 🎯$135
Price at call : $113.54 — gap to target +19%
Today : $182.03 — gap to target -26%
🎯 on RGEN : no call matured yet · 📊 on Health : 49.1% · +10.3% (112 calls)
in progress (365j)
matures : Sep 12, 26
matures : Sep 12, 26
HC Wainwright & Co. ↗
Sep 3, 25
▲ Buy · 🎯$180
Price at call : $116.18 — upside +55%
Today : $182.03 — upside -1%
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
RBC Capital ↗
Jul 30, 25
▲ Outperform · 🎯$204
Price at call : $117.07 — upside +74%
Today : $182.03 — upside +12%
Expected +74% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 20% (5 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+20.4%
stock +20% · XLV +25%
matured Jul 30, 26
Wells Fargo ↗
Jul 30, 25
▲ Overweight · 🎯$175
Price at call : $117.07 — upside +49%
Today : $182.03 — upside -4%
Expected +49% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 50% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+20.4%
stock +20% · XLV +25%
matured Jul 30, 26
Evercore ISI Group ↗
Jul 8, 25
■ In-Line neutral · not a buy · 🎯$130
Price at call : $128.56 — gap to target +1%
Today : $182.03 — gap to target -29%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Jul 8, 26
matures : Jul 8, 26
▲ Overweight · 🎯$150
Price at call : $123.35 — upside +22%
Today : $182.03 — upside -18%
Expected +22% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.9% · +1.6% (194 calls)
+12.2%
stock +12% · XLV +15%
matured Jun 24, 26
HC Wainwright & Co. ↗
May 5, 25
▲ Buy · 🎯$180
Price at call : $140.92 — upside +28%
Today : $182.03 — upside -1%
Expected +28% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-10.9%
stock -11% · XLV +5%
matured May 5, 26
RBC Capital ↗
Apr 30, 25
▲ Outperform · 🎯$189
Price at call : $137.2 — upside +38%
Today : $182.03 — upside +4%
Expected +38% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 20% (5 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-14.6%
stock -15% · XLV +6%
matured Apr 30, 26
▲ Overweight · 🎯$190
Price at call : $137.99 — upside +38%
Today : $182.03 — upside +4%
Expected +38% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
-14.3%
stock -14% · XLV +4%
matured Apr 29, 26
Canaccord Genuity ↗
Apr 16, 25
■ Hold neutral · not a buy · 🎯$150
Price at call : $130 — gap to target +15%
Today : $182.03 — gap to target -18%
🎯 on RGEN : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Apr 16, 26
matures : Apr 16, 26
Evercore ISI Group ↗
Mar 18, 25
■ In-Line neutral · not a buy · 🎯$155
Price at call : $144.34 — gap to target +7%
Today : $182.03 — gap to target -15%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Mar 18, 26
matures : Mar 18, 26
RBC Capital ↗
Feb 21, 25
▲ Outperform · 🎯$205
Price at call : $164.74 — upside +24%
Today : $182.03 — upside +13%
Expected +24% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 20% (5 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-17.8%
stock -18% · XLV +7%
matured Feb 21, 26
▲ Overweight · 🎯$200
Price at call : $164.74 — upside +21%
Today : $182.03 — upside +10%
Expected +21% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
-17.8%
stock -18% · XLV +7%
matured Feb 21, 26
HC Wainwright & Co. ↗
Feb 21, 25
▲ Buy · 🎯$180
Price at call : $158.99 — upside +13%
Today : $182.03 — upside -1%
Expected +13% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-14.8%
stock -15% · XLV +8%
matured Feb 21, 26
Canaccord Genuity ↗
Feb 21, 25
■ Hold neutral · not a buy · 🎯$170
Price at call : $158.99 — gap to target +7%
Today : $182.03 — gap to target -7%
🎯 on RGEN : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
HC Wainwright & Co. ↗
Jan 23, 25
▲ Buy · 🎯$180
Price at call : $167.9 — upside +7%
Today : $182.03 — upside -1%
Expected +7% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-3.3%
stock -3% · XLV +9%
matured Jan 23, 26
HC Wainwright & Co. ↗
Jan 22, 25
▲ Buy · 🎯$180
Price at call : $166.84 — upside +8%
Today : $182.03 — upside -1%
Expected +8% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+0.7%
stock +1% · XLV +11%
matured Jan 22, 26
Canaccord Genuity ↗
Dec 17, 24
■ Hold neutral · not a buy · 🎯$165
Price at call : $147.34 — gap to target +12%
Today : $182.03 — gap to target -9%
🎯 on RGEN : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Dec 17, 25
matures : Dec 17, 25
Wolfe Research ↗
Nov 14, 24
■ Peer Perform neutral · not a buy
🎯 on RGEN : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Nov 14, 25
matures : Nov 14, 25
RBC Capital ↗
Sep 26, 24
▲ Outperform · 🎯$205
Price at call : $145.93 — upside +40%
Today : $182.03 — upside +13%
Expected +40% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 20% (5 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-15.0%
stock -15% · XLV -11%
matured Sep 26, 25
Wells Fargo ↗
Aug 28, 24
▲ Overweight · 🎯$180
Price at call : $145.43 — upside +24%
Today : $182.03 — upside -1%
Expected +24% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 50% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
-16.0%
stock -16% · XLV -12%
matured Aug 28, 25
■ Hold neutral · not a buy
🎯 on RGEN : no call matured yet · 📊 on Health : 70% · +18.4% (10 calls)
in progress (365j)
matures : Aug 5, 25
matures : Aug 5, 25
▲ Overweight · 🎯$200
Price at call : $165.67 — upside +21%
Today : $182.03 — upside +10%
Expected +21% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
-28.2%
stock -28% · XLV -13%
matured Jul 31, 25
▲ Buy · 🎯$185
Price at call : $165.67 — upside +12%
Today : $182.03 — upside +2%
Expected +12% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 49.6% · +18.1% (119 calls)
-28.2%
stock -28% · XLV -13%
matured Jul 31, 25
RBC Capital ↗
Jul 31, 24
▲ Outperform · 🎯$190
Price at call : $165.67 — upside +15%
Today : $182.03 — upside +4%
Expected +15% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 20% (5 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-28.2%
stock -28% · XLV -13%
matured Jul 31, 25
HC Wainwright & Co. ↗
May 5, 21
▲ Buy · 🎯$240
Price at call : $194.81 — upside +23%
Today : $182.03 — upside +32%
Expected +23% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-18.6%
stock -19% · XLV +6%
matured May 5, 22
HC Wainwright & Co. ↗
Apr 12, 21
▲ Buy · 🎯$225
Price at call : $207.02 — upside +9%
Today : $182.03 — upside +24%
Expected +9% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-24.3%
stock -24% · XLV +17%
matured Apr 12, 22
HC Wainwright & Co. ↗
Aug 24, 20
▲ Buy · 🎯$168
Price at call : $145.99 — upside +15%
Today : $182.03 — upside -8%
Expected +15% · Actual +85% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+85.2%
stock +85% · XLV +28%
matured Aug 24, 21
HC Wainwright & Co. ↗
Jun 30, 20
▲ Buy · 🎯$151
Price at call : $123.61 — upside +22%
Today : $182.03 — upside -17%
Expected +22% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+61.5%
stock +61% · XLV +26%
matured Jun 30, 21
HC Wainwright & Co. ↗
May 7, 20
▲ Buy · 🎯$143
Price at call : $122.25 — upside +17%
Today : $182.03 — upside -21%
Expected +17% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+53.6%
stock +54% · XLV +25%
matured May 7, 21
HC Wainwright & Co. ↗
Mar 23, 20
▲ Buy · 🎯$100
Price at call : $94.68 — upside +6%
Today : $182.03 — upside -45%
Expected +6% · Actual +100% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+99.7%
stock +100% · XLV +42%
matured Mar 23, 21
HC Wainwright & Co. ↗
Jul 22, 19
▲ Buy
Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+52.9%
stock +53% · XLV +16%
matured Jul 21, 20
Frequently asked questions
Should I buy Repligen stock?
This isn't buy advice. For Repligen, the analyst consensus is "Buy", with an average price target of $160 (-12% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Repligen). We show the numbers — you decide.
Is it too late to buy Repligen? How high can it go?
The most bullish analyst target on Repligen is $208 (+14% above today's price); the average is $160. That's the upside they see. Check how reliable those analysts have actually been on Repligen on our site before trusting it.
Is Repligen still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 12 analysts have a real record on Repligen, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Repligen? The case for and against
The arguments for and against, one by one, from the numbers: why invest in RGEN (and why hesitate).
What has Repligen's past performance been?
Historical returns and a "how much if I had invested" calculator: RGEN performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX